A healthy body stays healthy due to all kinds of enzymes in the body being in proper balance. Excess of an enzyme can disturb balance while deficiency of another one can have the same effect

CAGR of 7.8 per cent is expected for the forecast period between 2022 and 2027, bringing the total global cosmetic surgery market to USD 21.97 billion

The demand for self-diagnosing kits and devices has amplified as the number of coronavirus cases has improved around the world

According to MRFR analysis, the global microcatheters market is expected to register a CAGR of~4.1% from 2021 to 2027 and hold a value of ~USD 2,412.0 million in 2027

The influenza vaccines market is expected to grow at a 6.53 percent CAGR by 2025,

According to MRFR analysis, Biosimulation Market is expected to register a CAGR of 15.9% during the forecast period of 2019 to 2025

the allergy immunotherapy market in the global market will grow at a higher CAGR of 10.85% by the end of the forecasted period and account for a market share of approximately 4.32 billion by the end of the forecasted period from 2022 to 2027

The biosensor market is projected to grow at a CAGR of 9.7% during the forecast period

It is estimated that the global Vascular Closure Devices Market Share is expected to register a CAGR ~ 6.8% during the forecast period

Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries

Sinus is also called as chronic rhinosinusitis; it is a condition in which cavities around nasal known as (sinuses) get inflamed and swollen for weeks

The assisted reproductive technology (ART) market is expected to witness tremendous growth owing to the rising prevalence of infertility in males as well as females

The transthyretin amyloidosis market is expected to register a sturdy growth during the forecast period

As per Market Research Future (MRFR)’s latest report, the global blood transfusion diagnostics market is set to expand at a CAGR of 8.2% during the forecast period

As per the reports by MRFR, the hemophilia treatment market is likely to project a robust CAGR of 6.10% during the review timeframe from 2022 to 2027.